Advanced in Breast Cancer

Tomas Reinert

Caxias Do Sul, RS, BR 
Advanced in Breast Cancer
Caxias Do Sul, RS, BR 
OverviewLocationsClinical Research

Overview

Tomas Reinert practices in Caxias Do Sul, Brazil. Mr. Reinert is rated as an Advanced expert by MediFind in the treatment of Breast Cancer. His top areas of expertise are Breast Cancer, COVID-19, BRCA Positive Breast Cancer, Amenorrhea, and Hormone Replacement Therapy (HRT).

His clinical research consists of co-authoring 50 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 45 articles and participated in 2 clinical trials in the study of Breast Cancer.

Gender
Male

Locations

Caxias Do Sul, RS, Brazil
Other Locations
Porto Alegre, RS, Brazil
Sao Paulo, SP, Brazil
Bairro Da Serra, SP, Brazil
Rio De Janeiro, RJ 20230130, Brazil
RJ, Brazil

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Multicenter, Prospective, Real World, National Study to Assess the Efficacy and Safety of Adjuvant Biosimilar Tratuzumab (Zedora) Treatment in Patients With Localized Her2 Positive Breast Cancer
A Multicenter, Prospective, Real World, National Study to Assess the Efficacy and Safety of Adjuvant Biosimilar Tratuzumab (Zedora) Treatment in Patients With Localized Her2 Positive Breast Cancer
Enrollment Status: Active_not_recruiting
Publish Date: October 24, 2024
Prospective Evaluation of Breast Cancer at Brazilian Institutions - Project AMAZONA III
Prospective Evaluation of Breast Cancer at Brazilian Institutions - Project AMAZONA III
Enrollment Status: Completed
Publish Date: June 15, 2021
A Randomized, Multicenter, Multinational, Double-Blind Study to Assess the Efficacy and Safety of MB02 (Bevacizumab Biosimilar Drug) Versus Avastin® in Combination With Carboplatin and Paclitaxel for the Treatment of Subjects With Stage IIIB/IV Non-squamous Non-Small Cell Lung Cancer (NSCLC)
A Randomized, Multicenter, Multinational, Double-Blind Study to Assess the Efficacy and Safety of MB02 (Bevacizumab Biosimilar Drug) Versus Avastin® in Combination With Carboplatin and Paclitaxel for the Treatment of Subjects With Stage IIIB/IV Non-squamous Non-Small Cell Lung Cancer (NSCLC)
Enrollment Status: Completed
Publish Date: April 26, 2021
Intervention Type: Drug
Study Phase: Phase 3
View 2 Less Clinical Trials

50 Total Publications

Real-World Data on First-Line Treatment of Hormone Receptor-Positive, HER2-Negative, Metastatic Breast Cancer in Brazil (BRAVE Study).
Real-World Data on First-Line Treatment of Hormone Receptor-Positive, HER2-Negative, Metastatic Breast Cancer in Brazil (BRAVE Study).
Journal: Clinical breast cancer
Published: March 19, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Reinert's expertise for a condition
ConditionClose
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile